Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
6.43B | 6.78B | 7.94B | 5.93B | 4.00B | Gross Profit |
2.46B | 1.90B | 2.32B | 1.85B | 1.31B | EBIT |
-562.00M | -1.38B | -894.00M | -1.19B | -720.00M | EBITDA |
7.78B | 10.47B | 19.15B | 7.75B | 4.03B | Net Income Common Stockholders |
2.85B | 4.33B | 12.22B | 5.30B | 3.10B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
19.26B | 20.63B | 13.14B | 6.12B | 8.17B | Total Assets |
62.27B | 65.50B | 71.32B | 53.82B | 36.32B | Total Debt |
16.50B | 16.45B | 16.15B | 8.27B | 3.86B | Net Debt |
14.68B | 7.13B | 6.93B | 4.84B | -272.00M | Total Liabilities |
20.99B | 20.89B | 21.19B | 12.96B | 6.39B | Stockholders Equity |
17.87B | 18.96B | 20.58B | 29.19B | 21.75B |
Cash Flow | Free Cash Flow | |||
936.00M | -479.00M | -981.00M | -62.00M | -310.00M | Operating Cash Flow |
1.03B | -177.00M | -702.00M | 73.00M | -196.00M | Investing Cash Flow |
142.00M | 12.55B | 5.91B | -731.00M | 2.32B | Financing Cash Flow |
-8.24B | -12.10B | 894.00M | 53.00M | 6.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | $23.76B | 12.75 | 48.41% | ― | 17.81% | 1175.52% | |
76 Outperform | $27.96B | 21.42 | 14.37% | 0.98% | 4.59% | 83.27% | |
76 Outperform | $91.09B | 281.08 | 4.41% | ― | 23.35% | ― | |
74 Outperform | $30.61B | 8.67 | 9.85% | ― | -1.33% | 32.92% | |
73 Outperform | $21.61B | 181.14 | 5.77% | ― | 64.12% | ― | |
63 Neutral | $49.68B | 16.30 | 17.75% | 0.15% | 11.37% | ― | |
61 Neutral | $14.79B | 5.90 | -3.99% | 6.20% | 2.67% | -30.30% |